8,787
Total Claims
$1.1M
Drug Cost
1,341
Beneficiaries
$799
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-48%
Cost per patient vs peers
$799 vs $1,524 avg
-2%
Brand preference vs peers
13.4% vs 13.7% avg
Brand vs Generic
87% generic
Brand: 1,177 claims · $912K
Generic: 7,610 claims · $159K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 492 | $434K |
| Sacubitril/Valsartan | 314 | $294K |
| Rivaroxaban | 66 | $54K |
| Evolocumab | 31 | $21K |
| Empagliflozin | 28 | $20K |
| Rosuvastatin Calcium | 781 | $15K |
| Evolocumab | 19 | $15K |
| Clopidogrel Bisulfate | 949 | $14K |
| Dronedarone Hcl | 12 | $9,752 |
| Dapagliflozin Propanediol | 11 | $8,570 |
| Ticagrelor | 15 | $7,960 |
| Metoprolol Succinate | 402 | $7,928 |
| Evolocumab | 12 | $7,737 |
| Prasugrel Hcl | 106 | $7,705 |
| Ranolazine | 71 | $7,311 |
Prescribing Profile
69
Unique Drugs
$811K
Patient Profile
74
Avg Age
49%
Female
1.51
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About